Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320112 · ClinicalTrials.gov registry record · Phase 3
Improving Insulin Therapy With Enhanced Care Management
A Phase 3 study of Diabetes, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 244
- Enrollment target
- 1
- Study location
NCT00320112 is a Phase 3 study of Diabetes that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 244 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00320112, a Phase 3 study of Diabetes, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 244 participants
- Enrollment target
- 1
- Study location
Study Summary
VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages.
Conditions Studied
Interventions
- BEHAVIORAL Reciprocal Diabetes Peer Support Program
- BEHAVIORAL Nurse Case management
- BEHAVIORAL group outpatient counseling visits
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320112
The ClinicalTrials.gov registry entry for NCT00320112 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Reciprocal Diabetes Peer Support Program is the first listed.
NCT00320112 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00320112 about?
NCT00320112 is a clinical study titled "Improving Insulin Therapy With Enhanced Care Management". VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as ini...
What is the current status of trial NCT00320112?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 244 participants. The study started on 2007-02. Estimated completion is 2010-03.
What conditions does trial NCT00320112 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00320112?
The interventions under investigation include: Reciprocal Diabetes Peer Support Program (BEHAVIORAL), Nurse Case management (BEHAVIORAL), group outpatient counseling visits (BEHAVIORAL).
Who is sponsoring clinical trial NCT00320112?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00320112 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial to Assess Chelation Therapy in Critical Limb Ischemia
RECRUITING · Phase 3
-
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
ACTIVE NOT RECRUITING · Phase 3
-
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
COMPLETED · Phase 3
-
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
COMPLETED · Phase 3
-
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
COMPLETED · Phase 3
-
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.